KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 130 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $38,000 | -47.9% | 11,279 | -41.6% | 0.00% | – |
Q2 2018 | $73,000 | -9.9% | 19,297 | -2.3% | 0.00% | -100.0% |
Q1 2018 | $81,000 | -43.0% | 19,744 | -35.3% | 0.00% | 0.0% |
Q4 2017 | $142,000 | +97.2% | 30,513 | +180.3% | 0.00% | – |
Q2 2016 | $72,000 | +26.3% | 10,885 | -11.0% | 0.00% | – |
Q1 2016 | $57,000 | +18.8% | 12,230 | +28.0% | 0.00% | – |
Q4 2015 | $48,000 | +6.7% | 9,558 | -24.8% | 0.00% | – |
Q3 2015 | $45,000 | +12.5% | 12,702 | +219.4% | 0.00% | – |
Q2 2015 | $40,000 | +2.6% | 3,977 | +28.4% | 0.00% | – |
Q1 2015 | $39,000 | -2.5% | 3,098 | +10.6% | 0.00% | – |
Q4 2014 | $40,000 | -9.1% | 2,800 | -13.0% | 0.00% | – |
Q3 2014 | $44,000 | -12.0% | 3,220 | -0.7% | 0.00% | – |
Q2 2014 | $50,000 | -12.3% | 3,242 | -3.8% | 0.00% | -100.0% |
Q1 2014 | $57,000 | +42.5% | 3,369 | +10.3% | 0.00% | – |
Q4 2013 | $40,000 | -62.6% | 3,054 | -71.2% | 0.00% | -100.0% |
Q3 2013 | $107,000 | +154.8% | 10,587 | +90.3% | 0.00% | – |
Q2 2013 | $42,000 | – | 5,562 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 1,605,800 | $16,026,000 | 4.65% |
Baupost Group | 25,791,678 | $257,401,000 | 4.29% |
1492 Capital Management LLC | 264,297 | $2,638,000 | 1.67% |
Cormorant Asset Management, LP | 826,000 | $8,243,000 | 1.10% |
FALCON POINT CAPITAL, LLC | 251,137 | $2,506,000 | 0.85% |
OAK RIDGE INVESTMENTS LLC | 3,291,711 | $32,851,000 | 0.70% |
Knoll Capital Management, LLC | 200,000 | $1,996,000 | 0.64% |
Rhenman & Partners Asset Management AB | 534,000 | $5,329,000 | 0.64% |
Old West Investment Management, LLC | 79,667 | $795,000 | 0.55% |
THREE BAYS CAPITAL LP | 1,284,000 | $12,814,000 | 0.53% |